Collar Badge Lens Dose Equivalent Values among United States Physicians Performing Fluoroscopically Guided Interventional Procedures.


Journal

Journal of vascular and interventional radiology : JVIR
ISSN: 1535-7732
Titre abrégé: J Vasc Interv Radiol
Pays: United States
ID NLM: 9203369

Informations de publication

Date de publication:
03 2022
Historique:
received: 09 04 2021
revised: 22 10 2021
accepted: 29 10 2021
pubmed: 9 11 2021
medline: 24 3 2022
entrez: 8 11 2021
Statut: ppublish

Résumé

To describe the range of occupational badge dose readings and annualized dose records among physicians performing fluoroscopically guided interventional (FGI) procedures using job title information provided by the same 3 major medical institutions in 2009, 2012, and 2015. The Radiation Safety Office of selected hospitals was contacted to request assistance with identifying physicians in a large commercial dosimetry database. All entries judged to be uninformative of occupational doses to FGI procedure staff were excluded. Monthly and annualized doses were described with univariate statistics and box-and-whisker plots. The dosimetry data set of interventional radiology staff contained 169 annual dose records from 77 different physicians and 698 annual dose records from 455 nonphysicians. The median annualized lens dose equivalent values among physicians (11.9 mSv; interquartile range [IQR], 6.9-20.0 mSv) was nearly 3-fold higher than those among nonphysician medical staff assisting with FGI procedures (4.0 mSv; IQR, 1.8-6.7 mSv) (P < .001). During the study period, without eye protection, 25% (23 of 93) of the physician annualized lens dose equivalent values may have exceeded 20 mSv; for nonphysician medical staff, this value may have been exceeded 3.5% (6 of 173) of the time. However, these values did not account for eye protection. The findings from this study highlight the importance of mitigating occupational dose to the eyes of medical staff, particularly physicians, performing or assisting with FGI procedures. Training on radiation protection principles, the use of personal protective equipment, and patient radiation dose management can all help ensure that the occupational radiation dose is adequately controlled.

Identifiants

pubmed: 34748952
pii: S1051-0443(21)01467-6
doi: 10.1016/j.jvir.2021.10.027
pmc: PMC10388339
mid: NIHMS1912621
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

219-224.e2

Subventions

Organisme : Intramural NIH HHS
ID : ZIA CP010133
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Références

Radiology. 2020 Feb;294(2):353-359
pubmed: 31769743
Ann ICRP. 2012 Feb;41(1-2):1-322
pubmed: 22925378
Occup Environ Med. 2019 May;76(5):317-325
pubmed: 30890565
J Interv Card Electrophysiol. 2019 Nov;56(2):183-190
pubmed: 30280302
Catheter Cardiovasc Interv. 2018 Mar 1;91(4):647-654
pubmed: 28707381
Phys Med. 2018 Aug;52:56-64
pubmed: 30139610
Radiat Prot Dosimetry. 2016 Sep;170(1-4):307-10
pubmed: 26891788
AJR Am J Roentgenol. 2017 Jun;208(6):1278-1284
pubmed: 28350475
J Vasc Interv Radiol. 2017 Mar;28(3):412-419
pubmed: 28111197
J Vasc Interv Radiol. 2020 Oct;31(10):1545-1550.e1
pubmed: 32861568
J Interv Cardiol. 2020 Aug 31;2020:9602942
pubmed: 32934609
Radiat Prot Dosimetry. 2020 Dec 30;192(3):321-327
pubmed: 33320204
JACC Cardiovasc Interv. 2017 Mar 13;10(5):520-528
pubmed: 28279321
Radiology. 2019 Mar;290(3):744-749
pubmed: 30644807
Health Phys. 2021 Mar 1;120(3):360-364
pubmed: 33475266
Radiat Prot Dosimetry. 2011 Mar;144(1-4):437-41
pubmed: 21051431
J Radiol Prot. 2017 Mar 20;37(1):43-58
pubmed: 27941226
AJR Am J Roentgenol. 2013 Jan;200(1):138-41
pubmed: 23255753
J Natl Cancer Inst Monogr. 2020 Jul 1;2020(56):188-200
pubmed: 32657347
Ann ICRP. 1991;21(1-3):1-201
pubmed: 2053748
Health Phys. 2018 Mar;114(3):328-343
pubmed: 29360710
J Vasc Interv Radiol. 2018 Mar;29(3):353-366
pubmed: 29306599
Radiology. 2017 Aug;284(2):482-494
pubmed: 28234559
Ann ICRP. 2018 Mar;47(2):1-118
pubmed: 29532669
Cardiovasc Intervent Radiol. 2010 Apr;33(2):230-9
pubmed: 20020300

Auteurs

David Borrego (D)

Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: david.borrego@nih.gov.

Craig Yoder (C)

Independent consultant, Weddington, North Carolina.

Stephen Balter (S)

Departments of Radiology and Medicine, Columbia University Medical Center, New York, New York.

Cari M Kitahara (CM)

Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH